Cargando…
Deaths related to differentiated thyroid cancer: a rare but real event
OBJECTIVE: The present study describes the clinical and tumor characteristics of patients that died from differentiated thyroid cancer and reports on the cause and circumstances of death in these cases. SUBJECTS AND METHODS: Retrospective analysis of all the differentiated thyroid cancer (DTC) relat...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Endocrinologia e Metabologia
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118796/ https://www.ncbi.nlm.nih.gov/pubmed/28699989 http://dx.doi.org/10.1590/2359-3997000000261 |
_version_ | 1785028876988055552 |
---|---|
author | Leite, Ana Kober N. Cavalheiro, Beatriz G. Kulcsar, Marco Aurélio Hoff, Ana de Oliveira Brandão, Lenine G. Cernea, Claudio Roberto Matos, Leandro L. |
author_facet | Leite, Ana Kober N. Cavalheiro, Beatriz G. Kulcsar, Marco Aurélio Hoff, Ana de Oliveira Brandão, Lenine G. Cernea, Claudio Roberto Matos, Leandro L. |
author_sort | Leite, Ana Kober N. |
collection | PubMed |
description | OBJECTIVE: The present study describes the clinical and tumor characteristics of patients that died from differentiated thyroid cancer and reports on the cause and circumstances of death in these cases. SUBJECTS AND METHODS: Retrospective analysis of all the differentiated thyroid cancer (DTC) related deaths at a single institution over a 5-year period, with a total of 33 patients. RESULTS: Most of the patients were female (63.6%), with a mean age at diagnosis of 58.2 years. The most common histologic type was papillary (66.7%) and 30.3% were follicular. The distribution according to the TNM classification was: 15.4% of T1; 7.7% T2; 38.4% T3; 19.2% of T4a and 19.2% of T4b. Forty-four percent of cases were N0; 20% N1a and 36.6% of N1b. Twelve patients were considered non-responsive to radioiodine. Only one of the patients did not have distant metastases. The most common metastatic site was the lung in 69.7%. The majority of deaths were due to pulmonary complications related to lung metastases (17 patients, 51.5%), followed by post-operative complications in 5 cases, neurological disease progression in 3 cases, local invasion and airway obstruction in one patient. Median survival between diagnosis and death was reached in 49 months while between disease progression and death it was at 22 months. CONCLUSION: Mortality from DTC is extremely rare but persists, and the main causes of death derive from distant metastasis, especially respiratory failure due to lung metastasis. Once disease progression is established, median survival was only 22 months. |
format | Online Article Text |
id | pubmed-10118796 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Sociedade Brasileira de Endocrinologia e Metabologia |
record_format | MEDLINE/PubMed |
spelling | pubmed-101187962023-04-21 Deaths related to differentiated thyroid cancer: a rare but real event Leite, Ana Kober N. Cavalheiro, Beatriz G. Kulcsar, Marco Aurélio Hoff, Ana de Oliveira Brandão, Lenine G. Cernea, Claudio Roberto Matos, Leandro L. Arch Endocrinol Metab Original Article OBJECTIVE: The present study describes the clinical and tumor characteristics of patients that died from differentiated thyroid cancer and reports on the cause and circumstances of death in these cases. SUBJECTS AND METHODS: Retrospective analysis of all the differentiated thyroid cancer (DTC) related deaths at a single institution over a 5-year period, with a total of 33 patients. RESULTS: Most of the patients were female (63.6%), with a mean age at diagnosis of 58.2 years. The most common histologic type was papillary (66.7%) and 30.3% were follicular. The distribution according to the TNM classification was: 15.4% of T1; 7.7% T2; 38.4% T3; 19.2% of T4a and 19.2% of T4b. Forty-four percent of cases were N0; 20% N1a and 36.6% of N1b. Twelve patients were considered non-responsive to radioiodine. Only one of the patients did not have distant metastases. The most common metastatic site was the lung in 69.7%. The majority of deaths were due to pulmonary complications related to lung metastases (17 patients, 51.5%), followed by post-operative complications in 5 cases, neurological disease progression in 3 cases, local invasion and airway obstruction in one patient. Median survival between diagnosis and death was reached in 49 months while between disease progression and death it was at 22 months. CONCLUSION: Mortality from DTC is extremely rare but persists, and the main causes of death derive from distant metastasis, especially respiratory failure due to lung metastasis. Once disease progression is established, median survival was only 22 months. Sociedade Brasileira de Endocrinologia e Metabologia 2017-03-20 /pmc/articles/PMC10118796/ /pubmed/28699989 http://dx.doi.org/10.1590/2359-3997000000261 Text en https://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Leite, Ana Kober N. Cavalheiro, Beatriz G. Kulcsar, Marco Aurélio Hoff, Ana de Oliveira Brandão, Lenine G. Cernea, Claudio Roberto Matos, Leandro L. Deaths related to differentiated thyroid cancer: a rare but real event |
title | Deaths related to differentiated thyroid cancer: a rare but real event |
title_full | Deaths related to differentiated thyroid cancer: a rare but real event |
title_fullStr | Deaths related to differentiated thyroid cancer: a rare but real event |
title_full_unstemmed | Deaths related to differentiated thyroid cancer: a rare but real event |
title_short | Deaths related to differentiated thyroid cancer: a rare but real event |
title_sort | deaths related to differentiated thyroid cancer: a rare but real event |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118796/ https://www.ncbi.nlm.nih.gov/pubmed/28699989 http://dx.doi.org/10.1590/2359-3997000000261 |
work_keys_str_mv | AT leiteanakobern deathsrelatedtodifferentiatedthyroidcancerararebutrealevent AT cavalheirobeatrizg deathsrelatedtodifferentiatedthyroidcancerararebutrealevent AT kulcsarmarcoaurelio deathsrelatedtodifferentiatedthyroidcancerararebutrealevent AT hoffanadeoliveira deathsrelatedtodifferentiatedthyroidcancerararebutrealevent AT brandaolenineg deathsrelatedtodifferentiatedthyroidcancerararebutrealevent AT cerneaclaudioroberto deathsrelatedtodifferentiatedthyroidcancerararebutrealevent AT matosleandrol deathsrelatedtodifferentiatedthyroidcancerararebutrealevent |